HCID 69004911, compound → HCID 58665064, compound

HRID 229834Notes

Reaction equation

[CH2:1]([O:8][C:9]([N:11]1[CH2:17][CH:16]([OH:18])[C@@H:15]([NH:19][C:20](=[O:34])[C@@H:21]([NH:26][C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])[CH2:22][CH:23]([CH3:25])[CH3:24])[CH2:14][CH2:13][C@H:12]1[CH3:35])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.CC(C)C[C@H](NC(C1C=C2C(=CC=1)N=CC=C2)=O)C(=O)N[C@H]1CC[C@@H](C)N(S(C2C=CC=CN=2)(=O)=O)CC1O>>[CH2:1]([O:8][C:9]([N:11]1[CH2:17][C:16](=[O:18])[C@@H:15]([NH:19][C:20](=[O:34])[C@@H:21]([NH:26][C:27]([O:29][C:30]([CH3:31])([CH3:33])[CH3:32])=[O:28])[CH2:22][CH:23]([CH3:25])[CH3:24])[CH2:14][CH2:13][C@H:12]1[CH3:35])=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

Reactant 2

HCID 69004911HCID 69004911, compound

HCID 86591324HCID 86591324, compound

Product 1

HCID 58665064HCID 58665064, compound

Procedure

Following the procedure of Example 12 (m), except substituting “(2R,5S)-5-((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoylamino)-2-methyl-6-hydroxy-azepane-1-carboxylic acid benzyl ester” for “quinoline-6-carboxylic acid {(S)-3-methyl-1-[(4S,7R)-7-methyl-3-hydroxy-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide gave the title compound: 1H NMR: 7.40-7.35 (m, 5H), 5.26 (m, 1H), 5.13 (dd, 1H), 4.91-4.78 (m, 2H), 4.47 (m, 1H), 4.12 (m, 1H), 3.64 (dd, 1H), 2.32 (m, 1H), 2.10 (m, 1H), 1.70-1.52 (m, 5H), 1.45 (s, 9H), 1.12 (d, 3H), 0.96 (s, 3H), 0.94 (s, 3H); Electrospray mass spec: M+H+=512.2.

Sources & evidence

ORD record: ord-8b71f00cf2fb4718821cd5be8e0c29cb
Source dataset: uspto-grants-2009_07
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07563784B2

Reaction notes

Loading…